ABBV News 56.44 07/01/2014 04:21:58 Abbvie Inc. Common Stock

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Abbvie Inc. Common Stock (ABBV) 56.44 $ABBV

Why Investors are Wrong about Gilead
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Mon Jun 30, 8:23PM CDT
Big biotech  Gilead  (Nasdaq: GILD) has gone on a tremendous 200% two year run as its groundbreaking hepatitis-C cure Sovaldi is breaking all expectations with $2.3 billion in just its first quarter of availability. This has led to nothing but...

Gilead Seeks Japanese Approval for Sovaldi - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 30, 4:11PM CDT
Gilead is looking to get Sovaldi approved in Japan.

AbbVie's Oncology Candidate Progresses - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 30, 3:45PM CDT
AbbVie Inc. (ABBV) announced that it has initiated a phase III study on its oncology candidate, veliparib.

Merger Monday: The AbbVie/Shire Saga Continues
Alex Dumortier, CFA, The Motley Fool - Motley Fool - Mon Jun 30, 9:19AM CDT
As we begin an abbreviated trading week due to the Independence Day holiday, U.S stocks are little changed on Monday morning, with the benchmark S&P 500 and the narrower Dow Jones Industrial Average up 0.14% and 0.08%, respectively, at 10:15...

European Stocks Are Mixed; Steady Inflation in Eurozone
at The Street - Mon Jun 30, 5:25AM CDT
European markets are mixed Monday after a relatively strong performance in Asia overnight.

Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK
PR Newswire - Mon Jun 30, 4:20AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Johnson & Johnson (NYSE: JNJ), AbbVie Inc (NYSE: ABBV), Valeant Pharmaceuticals Intl Inc (NYSE: VRX) and GlaxoSmithKline plc (ADR) (NYSE: GSK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4237-100free.

Tax-Fleeing Takeover Mania Surges Forward
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sat Jun 28, 12:17PM CDT
Health-care companies are increasingly looking to flee the U.S. for lower corporate tax rates and to access cash trapped overseas. While all deals will pale in comparison with Pfizer 's failed pursuit of AstraZeneca , that would-be deal has...

Shire Snubs AbbVie Offer Again, Favorable Ruling for Vyvanse - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 26, 1:25PM CDT
Shire (SHPG) recently announced that it continues to maintain its stance against AbbVie (ABBV)'s acquisition offer.

3 Stocks Boosting The Health Care Sector Higher
at The Street - Thu Jun 26, 12:02PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.

Closer Look at Gilead's Slowing Hep C Prescriptions
at The Street - Thu Jun 26, 9:23AM CDT
Is a slowdown in Sovaldi prescriptions the beginning of the highly anticipated "re-warehousing" of patients, or is some other factor at play?

AbbVie Announces Initiation of Pivotal Phase III Study of Veliparib (ABT-888) in Patients with Advanced Breast Cancer
PR Newswire - Thu Jun 26, 7:00AM CDT
AbbVie (NYSE: ABBV) today announced the initiation of a Phase III clinical trial evaluating the safety and efficacy of its investigational compound, veliparib (ABT-888), when added to carboplatin and paclitaxel, two chemotherapeutic medicines, in patients with advanced breast cancer. Specifically, the combination of veliparib, carboplatin and paclitaxel will be compared to treatment with carboplatin, paclitaxel and placebo in patients with human epidermal growth factor receptor 2-(HER2) negative metastatic or locally-advanced breast cancer, containing BRCA1 and/or BRCA2 gene mutations.

Stocks Hold Modest Gains; Shire Hits New High
at Investor's Business Daily - Wed Jun 25, 12:23PM CDT
Stocks continued to hold modest gains Wednesday afternoon after shaking off early losses caused by disappointing economic data. The Nasdaq and the S&P 500 were up 0.4% and 0.3%, respectively. Meanwhile, the Dow Jones industrial average was up 0.2%....

AbbVie cites tax break as a Shire deal motivator
By TOM MURPHY - AP - Wed Jun 25, 11:50AM CDT
U.S. drugmaker AbbVie sees a compelling tax break behind its roughly $46 billion bid to buy British counterpart Shire, and it expects the deal to expand Shire's global reach as well.

Why AbbVie (ABBV) Stock Is Gaining Today
at The Street - Wed Jun 25, 10:17AM CDT
Shares of AbbVie (ABBV) are up after the pharmaceuticals company presented its strategic rationale for acquiring Shire (SHPG).

Will Shire's Growth Plan Motivate AbbVie to Dig Deeper?
Cheryl Swanson, The Motley Fool - Motley Fool - Wed Jun 25, 8:30AM CDT
The market is already looking for AbbVie Inc to sweeten its recently rejected cash-and-shares offer of $46.5 billion for British drug maker Shire . But, by how much? And, assuming AbbVie comes up with yet another offer, will it be enough to...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
PR Newswire Europe - Wed Jun 25, 7:47AM CDT
- Materials for analyst and investor call in respect of possible offer for Shire plc
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 65

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
NestWorks' C500: Shaking Up CNC at Formnext 2026

Updated Category News Views 108

NestWorks C500: A Game Changer for Makers Folks, gather 'round, because NestWorks is turning heads with their C500 desktop CNC machine. As it lands firmly on TIME’s Best Inventions of 2026 list, this ain't just another gadget adorning a workshop—all eyes are on it at Formnext 2026. From November 17–20, Frankfurt is the stage where NestWorks plans to showcase how...

Continue Reading
Guangdong-US Trade: LED Screens, Beef & Trust Make Waves

Updated Category News Views 29

Guangdong's Economic Ballet with the U.S. Grab a cup of coffee, and let's unravel how Guangdong and the U.S. are tangoing their way through trade like nobody's business! Guangdong, the heavyweight champ for U.S.-China trade transactions, notched up a cool 685.27 billion yuan ($102 billion) in the first eight months of 2026. That's a healthy jump of 6.9% year on year, mind...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 65

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
Ballard's Q3 2026: Navigating Losses and Bold Moves

Updated Category News Views 53

Ballard’s Financial Puzzles in Q3 2026 Riding the rough waters of the third quarter in 2026, Ballard Power Systems set out its stall with some eyebrow-raising numbers. This ain't the bustling diner vibe we normally see for a thriving business. The results paint a cautious picture sprinkled with strategic shifts that demand a keen eye. GeoPura Acquisition: A Strategic...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 164

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
MacKenzie-Childs Grinds Into Spotlight with Oprah's Nod

Updated Category News Views 40

Oprah's Golden Touch: 30 Years Strong Every year, there are a few select spots that brands covet like a hawk on a rabbit hunt. Getting on Oprah’s 'Favorite Things' list is surely one of them. Just like that, the MacKenzie-Childs Electric Salt and Pepper Grinder Set has muscled its way into the 2026 selection. Spare me the bells and whistles; this is like hitting the...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 125

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 115

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 59

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading

Top 5 Most Recently Viewed Articles

Concentrix Unveils Ambitious Sustainability Goals for 2025

Updated Category News Views 366

Concentrix Releases Significant Sustainability Report Concentrix Corporation (NASDAQ: CNXC), a leader in global technology and services, recently revealed its 2025 Sustainability Report titled ‘The Power of One’. This comprehensive document showcases the company’s commitment to achieving its 2030 environmental, social, and governance (ESG) goals. These objectives...

Continue Reading
Hingham Institution for Savings Achieves Remarkable Q3 Growth

Updated Category News Views 193

Summary of Third Quarter Financial Results Hingham Institution for Savings (NASDAQ: HIFS) recently announced its financial results for the quarter ending September 30, 2025, reflecting a significant leap in profitability and growth metrics. The bank’s strategic approach and operational focus have led to these favorable outcomes. Earnings Overview The net income for the...

Continue Reading
Birchtech Corp. Announces Third Quarter Earnings Call Details

Updated Category News Views 149

Birchtech Corp. Announces Third Quarter Earnings Call Details Birchtech Corp. (TSX:BCHT) (OTCQB:BCHT) is making waves in the specialty activated carbon industry. As a recognized leader in technologies for sustainable air and water treatment, this Texas-based company is gearing up for its third-quarter earnings call, scheduled for 5:00 p.m. Eastern Time on a Thursday in...

Continue Reading
Syntec Optics Enhances Product Lines for Next Generation Markets

Updated Category News Views 251

Syntec Optics Promotes Growth in the Satellite Sector Syntec Optics Holdings, Inc. (Nasdaq: OPTX), based in Rochester, New York, is making significant strides in the expanding space market. The company is not just a leader in advanced technology, defense, biomedical, and communications equipment but is now pivoting towards a profound expansion of its space products...

Continue Reading
Laura Celeste Updegraff: Trailblazer in Military Leadership and HR

Updated Category News Views 248

Celebrating Leadership and Achievement Laura Celeste Updegraff, MBA, MS, stands out as a magnificent figure in leadership, recognized within The Inner Circle as a Pinnacle Professional Member Inner Circle of Excellence. Her remarkable journey highlights a deep commitment to service in the U.S. Army and a strong dedication to human resources leadership. A Distinguished...

Continue Reading